Form 4 Filing for Disc Medicine, Inc.

This Form 4 filing details a transaction by Georges Gemayel, a director at Disc Medicine, Inc. On June 18, 2026, Gemayel acquired 6,212 stock options with a right to buy, at a transaction price of $0.00 per share. These options are exercisable upon the first to occur of the Company's 2027 annual meeting or the one-year anniversary of the grant date, contingent upon continued service. The underlying securities are 6,212 shares of Common Stock. The option has an exercise price of $70.79 and expires on June 17, 2036. Following this transaction, Gemayel directly owns 6,212 shares.